این سایت در حال حاضر پشتیبانی نمی شود و امکان دارد داده های نشریات بروز نباشند
Iranian Journal of Blood and Cancer، جلد ۱۵، شماره ۱، صفحات ۱-۹
عنوان فارسی
چکیده فارسی مقاله
کلیدواژه‌های فارسی مقاله
عنوان انگلیسی Evaluation the Effect of Chemotherapy Drugs and Thiosemicarbazone Complexes on the Expression of URHC and CASC15 LncRNAs in Acute Lymphoblastic Leukemia Cell Line
چکیده انگلیسی مقاله Background: Acute lymphoblastic leukemia (ALL) is a common type of leukemia in children, accounting for about 30% of pediatric malignancies. Researchers aimed to assess the impact of chemotherapy drugs and Thiosemicarbazone complexes on the expression of URHC and CASC15 LncRNAs in Jurkat E6.1 cell line, which represents Acute Lymphoblastic Leukemia. Thiosemicarbazone complexes are a group of chemical compounds known for their antitumor activities. Material and Methods: Optimal doses of chemotherapy drugs and thiosemicarbazone complexes were prepared and administered to the cell line at different time points (24, 48, and 72 hours). RNA extraction and cDNA synthesis were performed, and the expression of URHC, CASC15, and GAPDH genes was measured using Real-time PCR. Statistical analysis was conducted on the obtained results. Results: The study found that complex 3, a combination of two chemotherapy drugs (Cytarabine and 6MP) at specific concentrations (1 mM and 5 mM, respectively), significantly reduced the expression of URHC after 72 hours. Similarly, treatment with Arac at 5 mM for 72 hours showed the most effective concentration and time for decreasing the expression of CASC15 LncRNAs. Conclusion: In conclusion, the research demonstrated that the studied drugs had a positive impact on reducing the expression of CASC15 and URHC onco-lncRNAs. However, the optimal effects varied depending on the concentrations and treatment durations. These findings highlight the potential of the examined drugs in targeting specific LncRNAs associated with Acute Lymphoblastic Leukemia.
کلیدواژه‌های انگلیسی مقاله Acute lymphoblastic leukemia, Chemotherapy, Thiosemicarbazone, lncRNA
نویسندگان مقاله | Arezoo Hassani
Department of Genetics, Zanjan Branch, Islamic Azad University, Zanjan, Iran


| Golnaz Asaadi Tehrani
Department of Genetics, Zanjan Branch, Islamic Azad University, Zanjan, Iran


| Neda Zahmatkesh
Department of Genetics, Zanjan Branch, Islamic Azad University, Zanjan, Iran


| Sina Mirzaahmadi
Department of Genetics, Zanjan Branch, Islamic Azad University, Zanjan, Iran.
نشانی اینترنتی http://ijbc.ir/browse.php?a_code=A-10-889-1&slc_lang=en&sid=1
فایل مقاله فایلی برای مقاله ذخیره نشده است
کد مقاله (doi)
زبان مقاله منتشر شده en
موضوعات مقاله منتشر شده Adults Hematology & Oncology
نوع مقاله منتشر شده
برگشت به: صفحه اول پایگاه   |   نسخه مرتبط   |   نشریه مرتبط   |   فهرست نشریات